-
NICE recommends a weekly injection for treating growth failure in children
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
-
NICE recommends Enhertu for more people with advanced breast cancer
Hundreds more people eligible for breast cancer drug Enhertu as NICE recommends it for earlier stage disease, in final draft guidance.
-
More than 5,200 people could benefit after NICE broadens recommendation on chronic lung disease treatment
NICE broadens recommendation on chronic lung disease treatment
-
New life-extending treatment for rare forms of advanced gastroesophageal cancer recommended by NICE
Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).
-
Fetal balloon procedure is safe for delivering ‘stuck’ babies, NICE says
A balloon inflated underneath a baby’s head after they have become stuck in the pelvis during labour could be used to safely deliver them, NICE has said.
-
Targeted treatment for rare form of aggressive lung cancer gets NICE approval
Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer
-
NICE recommends 3 treatments for COVID-19 in draft guidance
Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.
-
NICE recommends adapted shoes for people with severe osteoarthritis
People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.
-
NICE final draft guidance adds further treatment option for triple-negative breast cancer
NICE has today (8 November 2022) published final draft guidance which recommends pembrolizumab as an option for people with a type of breast cancer called triple-negative breast cancer.